FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034067524> ?p ?o ?g. }

• W3034067524 endingPage "326" @default.
• W3034067524 startingPage "321" @default.
• W3034067524 abstract "The role of cytoreductive nephrectomy (CN) patients with metastatic renal cell carcinoma (mRCC) is unclear. To define the proportion of symptomatic mRCC, to investigate the impact of CN on symptomatic improvement and perioperative morbidity, and to elucidate the trade-off between such benefit and harm, an observational study of 317 mRCC patients treated with CN was performed. Symptomatic mRCC was defined as the presence of any sign or symptom causally related to the disease. Sign or symptom resolution and improvement were defined as the absence of all the signs and symptoms recorded at baseline, and the absence of at least one sign or symptom recorded at baseline, respectively. Perioperative morbidity was assessed using the Clavien-Dindo classification. Response to CN was classified as beneficial, mixed, or harmful according to the trade-off between symptomatic improvement and perioperative morbidity. The proportions of local, metastasis-specific, and general signs or symptoms were 37%, 23%, and 27%, respectively. The proportions of any sign or symptom resolution and improvement after CN were 43% and 71%, respectively. The proportions of local sign or symptom resolution and improvement after CN were 91% and 95%, respectively. The risks of any complication and major complication were 37% and 10%, respectively. At regression analysis, symptomatic status was not associated with perioperative morbidity. The proportion of beneficial response was invariably higher than the proportion of harmful response. At mRCC diagnosis, two out of three patients suffer from any sign or symptom, and one out of three suffers from local signs or symptoms. CN has a positive impact on symptomatic status. Most metastatic renal cell carcinoma patients are symptomatic, and they should be aware that cytoreductive nephrectomy has a positive impact on symptomatic status." @default.
• W3034067524 created "2020-06-12" @default.
• W3034067524 creator A5003101912 @default.
• W3034067524 creator A5022182189 @default.
• W3034067524 creator A5024524740 @default.
• W3034067524 creator A5031550729 @default.
• W3034067524 creator A5038974730 @default.
• W3034067524 creator A5039363062 @default.
• W3034067524 creator A5040737038 @default.
• W3034067524 creator A5045675217 @default.
• W3034067524 creator A5058341802 @default.
• W3034067524 creator A5061623935 @default.
• W3034067524 creator A5063221736 @default.
• W3034067524 creator A5067922754 @default.
• W3034067524 creator A5071443011 @default.
• W3034067524 creator A5083257135 @default.
• W3034067524 date "2020-09-01" @default.
• W3034067524 modified "2023-09-30" @default.
• W3034067524 title "Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines" @default.
• W3034067524 cites W1581688971 @default.
• W3034067524 cites W2002640433 @default.
• W3034067524 cites W2008374848 @default.
• W3034067524 cites W2072478300 @default.
• W3034067524 cites W2081107186 @default.
• W3034067524 cites W2099752220 @default.
• W3034067524 cites W2144173184 @default.
• W3034067524 cites W2805060661 @default.
• W3034067524 cites W2805993607 @default.
• W3034067524 cites W2892325025 @default.
• W3034067524 cites W2898405766 @default.
• W3034067524 cites W2904657085 @default.
• W3034067524 cites W2907010595 @default.
• W3034067524 cites W2910097668 @default.
• W3034067524 cites W2911812451 @default.
• W3034067524 cites W2912691364 @default.
• W3034067524 cites W2913745075 @default.
• W3034067524 cites W2917524635 @default.
• W3034067524 cites W2946628936 @default.
• W3034067524 cites W2947020554 @default.
• W3034067524 cites W2949749413 @default.
• W3034067524 cites W2951459521 @default.
• W3034067524 cites W2959057164 @default.
• W3034067524 cites W2985979810 @default.
• W3034067524 cites W2997030355 @default.
• W3034067524 cites W2999941785 @default.
• W3034067524 cites W4210983935 @default.
• W3034067524 doi "https://doi.org/10.1016/j.eururo.2020.05.014" @default.
• W3034067524 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32507335" @default.
• W3034067524 hasPublicationYear "2020" @default.
• W3034067524 type Work @default.
• W3034067524 sameAs 3034067524 @default.
• W3034067524 citedByCount "24" @default.
• W3034067524 countsByYear W30340675242020 @default.
• W3034067524 countsByYear W30340675242021 @default.
• W3034067524 countsByYear W30340675242022 @default.
• W3034067524 countsByYear W30340675242023 @default.
• W3034067524 crossrefType "journal-article" @default.
• W3034067524 hasAuthorship W3034067524A5003101912 @default.
• W3034067524 hasAuthorship W3034067524A5022182189 @default.
• W3034067524 hasAuthorship W3034067524A5024524740 @default.
• W3034067524 hasAuthorship W3034067524A5031550729 @default.
• W3034067524 hasAuthorship W3034067524A5038974730 @default.
• W3034067524 hasAuthorship W3034067524A5039363062 @default.
• W3034067524 hasAuthorship W3034067524A5040737038 @default.
• W3034067524 hasAuthorship W3034067524A5045675217 @default.
• W3034067524 hasAuthorship W3034067524A5058341802 @default.
• W3034067524 hasAuthorship W3034067524A5061623935 @default.
• W3034067524 hasAuthorship W3034067524A5063221736 @default.
• W3034067524 hasAuthorship W3034067524A5067922754 @default.
• W3034067524 hasAuthorship W3034067524A5071443011 @default.
• W3034067524 hasAuthorship W3034067524A5083257135 @default.
• W3034067524 hasConcept C126322002 @default.
• W3034067524 hasConcept C141071460 @default.
• W3034067524 hasConcept C23131810 @default.
• W3034067524 hasConcept C2777472916 @default.
• W3034067524 hasConcept C2779134260 @default.
• W3034067524 hasConcept C2780091579 @default.
• W3034067524 hasConcept C2780227381 @default.
• W3034067524 hasConcept C31174226 @default.
• W3034067524 hasConcept C71924100 @default.
• W3034067524 hasConcept C81182388 @default.
• W3034067524 hasConceptScore W3034067524C126322002 @default.
• W3034067524 hasConceptScore W3034067524C141071460 @default.
• W3034067524 hasConceptScore W3034067524C23131810 @default.
• W3034067524 hasConceptScore W3034067524C2777472916 @default.
• W3034067524 hasConceptScore W3034067524C2779134260 @default.
• W3034067524 hasConceptScore W3034067524C2780091579 @default.
• W3034067524 hasConceptScore W3034067524C2780227381 @default.
• W3034067524 hasConceptScore W3034067524C31174226 @default.
• W3034067524 hasConceptScore W3034067524C71924100 @default.
• W3034067524 hasConceptScore W3034067524C81182388 @default.
• W3034067524 hasIssue "3" @default.
• W3034067524 hasLocation W30340675241 @default.
• W3034067524 hasOpenAccess W3034067524 @default.
• W3034067524 hasPrimaryLocation W30340675241 @default.
• W3034067524 hasRelatedWork W1973401238 @default.
• W3034067524 hasRelatedWork W2025535527 @default.
• W3034067524 hasRelatedWork W2033892848 @default.

• next